Factsheet

Q1 2020/21

---

______

Q1

Q1

Q1

Q1

19/20

20/21

19/20

20/21

Income statement, continuing operations

Growth drivers, continuing operations

Revenue

220.0

243.5

Organic growth

2%

10%

Gross profit

132.5

136.0

Volume/mix

na

5%

EBITDA b.s.i.

80.1

87.8

Price

na

5%

EBIT b.s.i.

63.8

61.4

Currencies

0%

-8%

Underlying EBIT b.s.i.1

63.8

63.4

M&A

0%

9%

EBIT

63.0

55.0

EUR growth

2%

11%

Net financial items

(2.6)

(6.6)

Organic growth by region, continuing operations

Profit for the period

49.9

41.4

EMEA

-3%

7%

Cash flow and investments, continuing operations

NA

8%

9%

Operating cash flow

29.9

38.8

LATAM

9%

40%

Investing cash flow

(28.7)

(376.2)

APAC

-2%

-4%

Free cash flow b.s.i.a.d

7.5

(6.9)

Food Cultures & Enzymes

M&A

-

(319.0)

Revenue

166.1

165.3

Balance sheet, Group

Organic growth

4%

8%

Total assets

2,096.8

3,228.7

Volume/mix

3%

2%

Invested capital

1,816.3

2,910.2

Currencies

-1%

-8%

Net working capital

244.1

250.4

M&A

-

-

Equity

727.2

930.7

EUR growth

3%

0%

Net interest-bearing debt

792.8

1,706.1

EBITDA

64.5

65.2

Key ratios

EBITDA margin

38.9%

39.4%

Continuing operations

EBIT

53.2

50.8

Gross margin

60.2%

55.9%

EBIT margin, %

32.1%

30.7%

EBITDA margin b.s.i.

36.4%

36.1%

ROIC excl. goodwill

36.7%

33.4%

EBIT margin b.s.i

29.0%

25.2%

Health & Nutrition

Underlying EBIT b.s.i. margin1

29.0%

28.5%

Revenue

53.9

78.2

EBIT margin

28.6%

22.6%

Organic growth

-4%

15%

R&D

9.3%

8.6%

Volume/mix

-4%

13%

Capex

10.5%

22.4%

Currencies

1%

-8%

Group

M&A

-

38%

ROIC excl. goodwill

27.8%

20.9%

EUR growth

-3%

45%

ROIC

15.7%

10.4%

EBITDA

15.6

22.6

Net debt to EBITDA b.s.i.

1.9x

3.8x

EBITDA margin

28.9%

28.9%

EBIT

10.6

10.6

Revenue split by

Revenue split by

business, YTD

region, YTD

EBIT margin, %

19.6%

13.6%

Underlying EBIT1

10.6

17.3

APAC

Underlying EBIT margin1, %

19.6%

22.1%

18%

H&N

EMEA

ROIC excl. goodwill

14.7%

7.2%

32%

37%

LATAM

1 See Q1 2020/21 company announcement, p. 20, for reconcilation of

13%

underlying margins.

FC&E

68%

NA 32%

Attachments

  • Original document
  • Permalink

Disclaimer

Chr. Hansen Holding A/S published this content on 14 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 January 2021 08:45:00 UTC